Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.

Literature DB >> 31881147

Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.

Sumeet A Khetarpal¹, Minxian Wang², Amit V Khera³.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2019 PMID： 31881147 PMCID： PMC7345071 DOI： 10.1056/NEJMc1912350

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

2 in total

1. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

Authors: Joseph L Witztum; Daniel Gaudet; Steven D Freedman; Veronica J Alexander; Andres Digenio; Karren R Williams; Qingqing Yang; Steven G Hughes; Richard S Geary; Marcello Arca; Erik S G Stroes; Jean Bergeron; Handrean Soran; Fernando Civeira; Linda Hemphill; Sotirios Tsimikas; Dirk J Blom; Louis O'Dea; Eric Bruckert
Journal: N Engl J Med Date: 2019-08-08 Impact factor: 91.245

2. Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors: Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal: N Engl J Med Date: 2014-06-18 Impact factor: 91.245

2 in total

5 in total

Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.

1. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

2. Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Review 1. Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

Review 2. Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention.

3. A Modern Approach to Dyslipidemia.

Review 4. Novel Experimental Agents for the Treatment of Hypercholesterolemia.

Review 5. Working towards full eradication of lipid-driven cardiovascular risk?